Media Inquiries

Ellen Berlin
617-632-5357
ellen_berlin@dfci.harvard.edu

Kristen Dattoli
617-919-3141
kristen.dattoli@ childrens.harvard.edu

More Information
Follow Us!
Twitter

Our Twitter handle is:

@DFBC_PedCare

April Apfelbaum, PhD, Costanza Lo Cascio, PhD, and James J. Morrow, MD, PhD named as part of the Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows

    Published:
Damon Runyon Cancer Research Fellows

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center is happy to announce three research fellows have been named as part of the Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows.

April A. Apfelbaum, PhD, Costanza Lo Cascio, PhD, and James J. Morrow, MD, PhD are three of the five members of the inaugural class. Each fellow will receive funding for four years ($300,000 total) to support their research.

April A. Apfelbaum, PhD, a member of the Bandopadhayay Lab, will focus on brain cancers. Her research hopes to uncover new therapeutic targets and mechanisms of FGFR1-mediated oncogenesis in pediatric gliomas, but since FGFR1 is commonly altered in many tumors, her findings may reveal a common oncogenic mechanism.

Costanza Lo Cascio, PhD, a member of the Filbin Lab, will focus on brain tumors. She aims to investigate critical genes in FGFR1-altered pediatric gliomas to understand the biological mechanisms driving these cancers. Her research hopes to uncover new therapeutic targets and mechanisms of FGFR1-mediated oncogenesis in pediatric gliomas, but since FGFR1 is commonly altered in many tumors, her findings may reveal a common oncogenic mechanism.

James J. Morrow, MD, PhD, a member of the Bernstein Lab, will focus on Osteosarcoma. His work focuses on understanding normal bone development and how this development goes awry, giving rise to osteosarcoma. He hopes this improved understanding will lead to new treatment approaches for pediatric osteosarcoma patients.